Breaking News Instant updates and real-time market news.

MDT

Medtronic

$88.53

0.515 (0.59%)

11:35
07/19/18
07/19
11:35
07/19/18
11:35

Medtronic starts enrollment in trial for ECG Belt for heart failure therapy

Medtronic announced first enrollments in a new clinical trial evaluating the ECG Belt Research System, ECG Belt, as a diagnostic tool for optimizing cardiac resynchronization therapy, CRT,for patients with heart failure. The first patient enrolled in the ECG Belt for CRT Response trial was at Mercy Medical Center - West Lakes in Des Moines, Iowa, by Troy Hounshell, D.O., Iowa Heart Center. The ECG Belt is investigational and not approved for sale in the United States. ECG Belt for CRT Response is a prospective, randomized, interventional, investigational study that will initially enroll patients in 10 centers across the U.S. The trial will compare patients treated with CRT and ECG Belt diagnostics to patients treated with standard CRT. The study will expand to additional sites worldwide to ensure a total of 400 randomized patients.CRT is an established treatment option for indicated patients with heart failure in which an implantable device sends low levels of energy through thin wires, called leads, to stimulate the lower chambers of the heart to improve its pumping efficiency. The therapy has been demonstrated to improve survival and quality of life, and to reduce hospitalizations."The aim of this technology is to give physicians immediate feedback that may impact clinical decision making at the time of implant and also during follow-up visits," said Dr. Hounshell, electrophysiologist at Iowa Heart Center, and the site's principal investigator in the study. "By pairing CRT with the ECG Belt, we have the potential to provide a more personalized and noninvasive approach to help heart failure patients."

  • 14

    Aug

  • 15

    Aug

MDT Medtronic
$88.53

0.515 (0.59%)

06/11/18
PIPR
06/11/18
NO CHANGE
Target $32.5
PIPR
Overweight
Piper doesn't see regulatory issues for possible Stryker, Boston Scientific deal
Piper Jaffray analyst Matt O'Brien believes regulatory constraints from Stryker's (SYK) potential acquisition of Boston Scientific (BSX) "should not be much of an issue" given the little overlap between the businesses. The deal structure would be the biggest issue facing Stryker as the company would likely have to lever up heavily to acquire Boston Scientific, O'Brien tells investors in a research note. The analyst believes a transaction could occur in the $52B-$54B range, assuming a typical medtech takeout premium of 20%-30%. Consequently, any transaction would either require a significant level of debt or dilution to Stryker shareholders, the analyst contends. He sees the potential deal as likely being dilutive until 2021. O'Brien has an Overweight rating on Boston Scientific with a $32.50 price target. The stock closed the trading day up 7% to $34.32 after the Wall Street Journal reported that Stryker approached the company regarding a takeover.
06/18/18
PIPR
06/18/18
NO CHANGE
Target $96
PIPR
Overweight
Piper continues to recommend Medtronic after management meeting
After meeting with management, Piper Jaffray analyst Matt O'Brien continues to recommend building positions in Medtronic (MDT). The analyst views management's 4% plus revenue outlook over the next several years as "readily achievable and likely conservative." Management noted that given the low penetration rates of surgery performed on robots, they did not see a reason to be aggressive on pricing of their system once they get it to market, O'Brien tells investors in a research note. He believes that is a positive comment for Intuitive Surgical (ISRG). The analyst keeps an Overweight rating on Medtronic with a $96 price target.
06/26/18
BMOC
06/26/18
NO CHANGE
Target $94
BMOC
Outperform
Medtronic Sugar IQ software 'underappreciated', says BMO Capital
BMO Capital analyst Joanne Wuensch kept her Outperform rating and $94 price target on Medtronic after its Diabetes Analyst Meeting at ADA yesterday. The analyst cites the company's message that it is investing in a comprehensive program to better treat diabetes patients while focusing on systems to reduce healthcare costs, having raised its market share and decreased preventable hospitalizations. Wuensch also believes that Medtronic's Sugar IQ software is underappreciated given its ability to start providing "customizable insights to patients after just five days of data collection".
06/27/18
BERN
06/27/18
INITIATION
Target $88
BERN
Market Perform
Medtronic initiated with a Market Perform at Bernstein
Bernstein analyst Lee Hambright started Medtronic with a Market Perform rating and $88 price target as he believes the company is undergoing "something of an identity crisis." After ardent pursuit of economic value and globalization strategies over the past 7 years, Medtronic messaging has recently shifted, with greater emphasis on technology leadership, he contends. The analyst believes the new messaging is the right move for the company, but thinks the stock is unlikely to work until the company can demonstrate consistent performance on margin and cash conversion commitments.

TODAY'S FREE FLY STORIES

PODD

Insulet

$105.84

-1.07 (-1.00%)

11:51
05/23/19
05/23
11:51
05/23/19
11:51
Options
Insulet trader rolls winning call block up 15 points »

Insulet trader rolls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

SFLY

Shutterfly

$48.78

0.48 (0.99%)

11:50
05/23/19
05/23
11:50
05/23/19
11:50
Options
Vertical call spread buyer in Shutterfly appears to be averaging down »

Vertical call spread…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:50
05/23/19
05/23
11:50
05/23/19
11:50
General news
Treasury's $85 B 4- and 8-week bill auctions were very poorly subscribed »

Treasury's $85 B 4-…

BA

Boeing

$347.78

-4.72 (-1.34%)

11:49
05/23/19
05/23
11:49
05/23/19
11:49
Hot Stocks
European pilot group urges EU regulator to put pressure on Boeing over 737 MAX »

The European Cockpit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

AAL

American Airlines

$29.87

-0.05 (-0.17%)

11:45
05/23/19
05/23
11:45
05/23/19
11:45
Options
American Airlines call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 12

    Jun

  • 12

    Jun

11:42
05/23/19
05/23
11:42
05/23/19
11:42
General news
4-Week Bill Auction Total Amount data reported »

4-Week Bill Auction Total…

11:42
05/23/19
05/23
11:42
05/23/19
11:42
General news
8-Week Bill Auction Total Amount data reported »

8-Week Bill Auction Total…

TXRH

Texas Roadhouse

$52.02

-2.99 (-5.44%)

, CMG

Chipotle

$664.71

-41.34 (-5.86%)

11:40
05/23/19
05/23
11:40
05/23/19
11:40
Recommendations
Texas Roadhouse, Chipotle analyst commentary at Baird »

Texas Roadhouse, Chipotle…

TXRH

Texas Roadhouse

$52.02

-2.99 (-5.44%)

CMG

Chipotle

$664.71

-41.34 (-5.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 13

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

CMG

Chipotle

$664.67

-41.38 (-5.86%)

, BLMN

Bloomin' Brands

$18.65

-1.55 (-7.67%)

11:31
05/23/19
05/23
11:31
05/23/19
11:31
On The Fly
Downgrades of Chipotle, Qualcomm headline today's top analyst calls »

Check out today's top…

CMG

Chipotle

$664.67

-41.38 (-5.86%)

BLMN

Bloomin' Brands

$18.65

-1.55 (-7.67%)

QCOM

Qualcomm

$67.38

-1.86 (-2.69%)

TGT

Target

$78.84

1.34 (1.73%)

AMZN

Amazon.com

$1,823.68

-34.06 (-1.83%)

WMT

Walmart

$101.31

-0.73 (-0.72%)

BKNG

Booking Holdings

$1,724.04

-21.46 (-1.23%)

EXPE

Expedia

$116.92

0.15 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 29

    May

  • 03

    Jun

  • 04

    Jun

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 07

    Jun

  • 07

    Jun

  • 12

    Jun

  • 18

    Jun

  • 24

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 31

    Jul

  • 15

    Aug

  • 13

    Nov

GE

General Electric

$9.62

-0.28 (-2.83%)

11:30
05/23/19
05/23
11:30
05/23/19
11:30
Options
Giant ratio spread in GE as shares drop 2.1% »

Giant ratio spread in GE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 05

    Jun

11:25
05/23/19
05/23
11:25
05/23/19
11:25
General news
Treasury announced $113 B in shorter coupons for auction »

Treasury announced $113 B…

11:25
05/23/19
05/23
11:25
05/23/19
11:25
Conference/Events
Stephens medical devices analyst to hold a group luncheon »

Medical Devices &…

ECA

Encana

$6.05

-0.435 (-6.71%)

11:20
05/23/19
05/23
11:20
05/23/19
11:20
Options
Notable call buy in Encana as shares dip »

Notable call buy in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTOO

T2 Biosystems

$1.88

-0.685 (-26.76%)

11:19
05/23/19
05/23
11:19
05/23/19
11:19
Hot Stocks
T2 Biosystems highlights clinical data at ECCMID, MAD-ID meetings »

T2 Biosystems highlighted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jun

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
05/23/19
05/23
11:17
05/23/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
05/23/19
05/23
11:16
05/23/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

8-Week Bill Auction to be…

11:15
05/23/19
05/23
11:15
05/23/19
11:15
General news
Breaking General news story  »

4-Week Bill Auction to be…

MICT

Micronet Enertec

$0.99

(0.00%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
Micronet Enertec receives two orders totaling $1.3M for SmartHub platform »

MICT announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQT

EQT Corporation

$19.64

-0.31 (-1.55%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Hot Stocks
EQT Corporation files definitive proxy, mails letter to shareholders »

EQT Corporation announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HTHT

Huazhu Group

$32.60

-1.81 (-5.26%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Downgrade
Huazhu Group rating change  »

Huazhu Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

USO

United States Oil Fund

$12.09

-0.66 (-5.18%)

11:10
05/23/19
05/23
11:10
05/23/19
11:10
Options
Customer rolls US Oil ETF puts for 233% gain as oil sells off »

Customer rolls US Oil ETF…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTLR

Rattler Midstream

$0.00

(0.00%)

, FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

11:09
05/23/19
05/23
11:09
05/23/19
11:09
Syndicate
Rattler Midstream opens at $18.06, IPO priced at $17.50 per share »

Rattler Midstream (RTLR)…

RTLR

Rattler Midstream

$0.00

(0.00%)

FANG

Diamondback Energy

$104.01

-4.86 (-4.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

  • 23

    May

FCX

Freeport McMoRan

$9.94

-0.11 (-1.09%)

11:05
05/23/19
05/23
11:05
05/23/19
11:05
Options
Freeport McMoRan call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

IBM

IBM

$132.49

-3.53 (-2.60%)

11:04
05/23/19
05/23
11:04
05/23/19
11:04
Hot Stocks
ProcessMap, IBM announce joint initiative to develop IoT solutions »

ProcessMAP and IBM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.